Agreed. I think the fud and doubt that has been seeded with this treatment is such a profoundly awful lie and so contrary to reality that it really should be a crime to engage in such misinformation. Granted, regulators and some in the area of medical research do make mistakes sometimes that seem to be driven by formalistic ideas that ultimately generate bad results and that can even persist for many years. I do not believe this is such a situation and I believe this should be a slam dunk for approval when you assemble all of the extraneous and direct evidence together and look at it all. Some of it is circumstantial, we look at other treatments that were approved and really probably should not have been approved at that time, if the formalistic arguments were truly governing decision making, like Novocure, but they were approved. In this case we have so much direct and indirect evidence that suggests not only should this be a slam dunk, but that it will be immensely successful and revolutionary in oncology broadly.
It is why so many of us held through difficult times with the shorts and their mouthpieces.
I am just another investor, but that is my belief and I am sticking to it.
Market Data 
Markets 
AI
